Clinical Trials on Autoimmune Neutropenia

Total 13088 results

Merck Sharp & Dohme LLC

Completed

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Fungal Infection | Neutropenia | Acute Myelogenous Leukemia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Decitabine for High-Risk Sickle Cell Disease

Neutropenia | Sickle Cell Disease

United States
University Hospital, Strasbourg, France

Recruiting

Patient-Reported AutoImmunity Secondary to Cancer immunothErapy (PRAISE)

Opportunistic Autoimmune Diseases

France
Innodem Neurosciences
Syneos Health

Recruiting

ETNA-MS Device Validation Study (ETNA-MS)

Multiple Sclerosis

United States
LAPIX Therapeutics Inc.

Recruiting

First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641

Multiple Sclerosis | Autoimmune Diseases

United States, Jordan
Biogen

Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Multiple Sclerosis

Spain, Ireland, United States, Germany
Nottingham University Hospitals NHS Trust
Johns Hopkins University

Not yet recruiting

Longitudinal Assessment of Iron Rims in MS Lesions

Multiple Sclerosis
University of Colorado, Denver
Genentech, Inc.

Recruiting

Home Based Infusions for Ocrelizumab

Multiple Sclerosis

United States
S. Andrea Hospital

Recruiting

Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)

Multiple Sclerosis

Italy
Johns Hopkins University

Completed

Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes

Multiple Sclerosis

United States
University of Chicago

Terminated

Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses (ACTHAR)

Multiple Sclerosis
Queen Mary University of London

Completed

Oral Cladribine B-cell Study

Multiple Sclerosis

United Kingdom
Turku University Hospital

Active, not recruiting

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression (TERIPET)

Multiple Sclerosis

Finland
GlaxoSmithKline

Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants

Multiple Sclerosis

United Kingdom
University Hospital, Bordeaux
Biogen

Completed

Safety of Exposure to Natalizumab During Pregnancy (BABYZUMAB-2)

Multiple Sclerosis

France, Martinique
Sanofi

Completed

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Multiple Sclerosis

United States
Sanofi

Completed

An Observational Study on Teriflunomide-exposed Pregnancies

Multiple Sclerosis

United States, Canada
Centre Hospitalier Universitaire de Nice
Genzyme, a Sanofi Company

Completed

Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome (TERIS)

Multiple Sclerosis

Turkey, France, Switzerland
Sanofi

Completed

Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks (TERI-PK)

Multiple Sclerosis

China
Novartis Pharmaceuticals

Completed

Impact of Fingolimod Adherence on Outcomes

Multiple Sclerosis

United States
Universitätsklinikum Hamburg-Eppendorf

Completed

Intermittent Hypoxia Intervention in MS Patients (MSHYPE)

Multiple Sclerosis

Germany
GeNeuro Australia PTY Ltd

Completed

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Multiple Sclerosis

Australia
Colorado State University

Completed

Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?

Multiple Sclerosis

United States
Biogen

Completed

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

Multiple Sclerosis

United States
University Hospital Muenster

Unknown

Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response (ProgramMS)

Multiple Sclerosis

Germany
Oregon Health and Science University

Completed

Exercise & Brain Health in MS

Multiple Sclerosis

United States
Clinique Neuro-Outaouais

Completed

Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting

Multiple Sclerosis

Canada
Clinique Neuro-Outaouais
CogState Ltd.

Completed

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

Multiple Sclerosis

Canada
Universitätsklinikum Hamburg-Eppendorf

Unknown

Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MS (VICTOR2)

Multiple Sclerosis

Germany
Kessler Foundation

Unknown

The SEMS Project: Staying Employed With MS

Multiple Sclerosis

United States
Multiple Sclerosis Center of Northeastern New York
Icahn School of Medicine at Mount Sinai; Biogen

Unknown

Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients

Multiple Sclerosis

United States
GlaxoSmithKline

Completed

GSK239512 DDI Study

Multiple Sclerosis

Australia
Biogen

Completed

Study of Utilization Patterns of Dimethyl Fumarate in Germany

Multiple Sclerosis

Germany
Kessler Foundation

Completed

Stylistic Memory Enhancement (SME)

Multiple Sclerosis
GlaxoSmithKline

Completed

GSK2018682 FTIH in Healthy Volunteers (P1A114070)

Multiple Sclerosis

Australia
Virginia Simnad
Biogen

Unknown

Impact of Tecfidera on Gut Microbiota

Multiple Sclerosis

United States
University at Buffalo

Completed

Natalizumab Temporary Discontinuation Study (NaTDS)

Multiple Sclerosis

United States
Brigham and Women's Hospital
EMD Serono

Withdrawn

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS

Multiple Sclerosis

United States
University Hospital, Caen

Unknown

Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS (ITEMS)

Multiple Sclerosis

France
EMD Serono
Pfizer

Completed

Rebif® Pregnancy Registry

Multiple Sclerosis

United States
University of Aarhus
Aarhus University Hospital; Danish MS Hospitals, Haslev and Ry; The Danish MS...

Completed

Exercise in Severely Disabled Patients With MS

Multiple Sclerosis

Denmark
Biogen

Completed

Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers

Multiple Sclerosis

United States
University Hospital, Strasbourg, France
Biogen

Terminated

Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri

Multiple Sclerosis

France
Kessler Foundation
Biogen

Completed

Psychometric Validation of Cognitive Endpoints

Multiple Sclerosis

United States
Newcastle University
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS) (RADS)

Autoimmune Adrenocortical Failure

United Kingdom
University of Illinois at Chicago

Not yet recruiting

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device (MSGH)

Multiple Sclerosis
The University of Texas at Dallas
Texas Institute for Neurological Disorders

Not yet recruiting

Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS

Multiple Sclerosis

United States
Fondazione Don Carlo Gnocchi Onlus
Fondazione Italiana Sclerosi Multipla; Ente Ospedaliero Ospedali Galliera

Recruiting

Effect of High Intensity Training on Motor and Cognitive Functions (FAST)

Multiple Sclerosis

Italy
Novartis Pharmaceuticals

Not yet recruiting

Kesimpta Pregnancy and Infant Safety Study Using Real World Data

Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial (WINDOCRE)

Multiple Sclerosis

France

Clinical Trials on Autoimmune Neutropenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations